BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guan Y, Yao W, Yi K, Zheng C, Lv S, Tao Y, Hei Z, Li M. Nanotheranostics for the Management of Hepatic Ischemia-Reperfusion Injury. Small 2021;17:e2007727. [PMID: 33852769 DOI: 10.1002/smll.202007727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Leng Q, Li Y, Zhou P, Xiong K, Lu Y, Cui Y, Wang B, Wu Z, Zhao L, Fu S. Injectable hydrogel loaded with paclitaxel and epirubicin to prevent postoperative recurrence and metastasis of breast cancer. Mater Sci Eng C Mater Biol Appl 2021;129:112390. [PMID: 34579909 DOI: 10.1016/j.msec.2021.112390] [Reference Citation Analysis]
2 Kong H, Ju E, Yi K, Xu W, Lao YH, Cheng D, Zhang Q, Tao Y, Li M, Ding J. Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma. Adv Sci (Weinh) 2021;:e2102051. [PMID: 34665528 DOI: 10.1002/advs.202102051] [Reference Citation Analysis]
3 Su R, Zhang Y, Zhang J, Wang H, Luo Y, Chan HF, Tao Y, Chen Z, Li M. Nanomedicine to advance the treatment of bacteria-induced acute lung injury. J Mater Chem B 2021;9:9100-15. [PMID: 34672317 DOI: 10.1039/d1tb01770e] [Reference Citation Analysis]
4 Yu Q, Chen S, Tang H, Zhang X, Tao R, Yan Z, Shi J, Guo W, Zhang S. Veratric acid alleviates liver ischemia/reperfusion injury by activating the Nrf2 signaling pathway. Int Immunopharmacol 2021;101:108294. [PMID: 34749250 DOI: 10.1016/j.intimp.2021.108294] [Reference Citation Analysis]